Nutrastar International Inc. (NUIN) Return on Investment ROI from the third quarter of 2015 to third quarter of 2014 and for the year 2015, average high and low, overall ranking from Sep 30 2015 to Sep 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nutrastar International Inc.  (NUIN)


Nutrastar International's ROI from its third quarter of 2015 to the third quarter of 2014 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nutrastar International's ROI in the third quarter of 2015?
Nutrastar International Inc. achieved a return on average invested assets (ROI) of 16.02 % in its third quarter of 2015, which is below Nutrastar International's average return on investment, which stands at 19.13%.

ROI decreased relative to the period ending Jun 30 2015, due to the decline in net income.

Within the Healthcare sector 68 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2015 from 0 to 599.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Investment Change TTM 17.98 % 20.12 % 21.18 % 22.75 % 25.07 %
Y / Y Net Income Change TTM 0.56 % 2.09 % 43.62 % 77.6 % 299.65 %
Investment (TTM) in Millions 150 150 142 139 132
Return On Investment (TTM) 16.02 % 16.59 % 17.12 % 17.67 % 18.79 %
NUIN's Overall Ranking # 599 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 3.24 % 4.51 % 4.53 % 4.61 % 5.11 %
Seq. Net Income Change TTM -0.29 % 1.23 % 1.31 % -1.65 % 1.22 %
Net Income (TTM) in Millions 23 23 23 23 23

NUIN Company Profile >> Back to NUIN Roi Comparisons >> See Annual NUIN Return On Investment



Return On Investment NUIN's Ranking
Within: No.
Industry # 4
Sector # 69
Overall # 599

Return On Investment Statistics
High Average Low
21.17 %
19.13 %
16.02 %
(Sep 30 2013)   (Sep 30 2015)







Financial Statements
Nutrastar International's III. Quarter Investments $ 150 Millions NUIN's Balance sheet
Nutrastar International's III. Quarter Income $ 6 Millions Quarterly NUIN's Income Statement
NUIN's Income by Division See NUIN's Income by Division


NUIN Annual Return On Investment (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011
Total Investments in Millions 139 116 90 72 0
Y / Y Investment Growth 19.51 % 28.67 % 25.38 % - -
Net Income in Millions 23 22 17 17 0
Y / Y Net Income Growth 2.48 % 28.58 % 1.53 % - -
Annual Return On Investment 16.36 % 19.08 % 19.1 % 23.58 % -


Annual Roi Comment
In the fiscal year 2014 ROI deteriorated to 16.36 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NUIN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NUIN's Competitors
Subscribers only: Roi for Nutrastar International's Suppliers
Subscribers only: Return On Investment for NUIN's Customers

Other Ratios
NUIN's Roa NUIN's Inventory Turnover Ratio NUIN's Growth Rates NUIN's Dividend Statistics
NUIN's Profitability Ratios NUIN's Asset Turnover Ratio NUIN's Dividend Growth
NUIN's Roe NUIN's Valuation Ratios NUIN's Financial Strength Ratios NUIN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2015, within Healthcare Sector ROI
Corbus Pharmaceuticals Holdings Inc   43.21 %
Fonar Corporation  43.12 %
Proteo Inc  42.96 %
Enanta Pharmaceuticals Inc  37.29 %
Pacific Health Care Organization Inc  36.99 %
Travere Therapeutics Inc   36.12 %
Lannett Company Inc  33.36 %
China Biologic Products Holdings Inc   26.03 %
Iridex Corp  25.61 %
Vanda Pharmaceuticals Inc   25.55 %
Biogen Inc   25.36 %
Lakeland Industries Inc   25.25 %
Mettler toledo International Inc   24.84 %
Biospecifics Technologies Corp  24.67 %
Sientra Inc   24.30 %
Misonix Inc   23.24 %
Journey Medical Corp  22.73 %
Meridian Bioscience Inc   21.54 %
Mimedx Group Inc   21.26 %
Insys Therapeutics, Inc.  19.98 %
Varian Medical Systems Inc   19.98 %
3m Company  19.26 %
Atrion Corporation  18.76 %
Tenax Therapeutics Inc   18.22 %
Retractable Technologies Inc  18.19 %
Oramed Pharmaceuticals Inc  18.19 %
Paratek Pharmaceuticals Inc   17.77 %
Resmed Inc   17.57 %
Illumina Inc   17.56 %
Healthcare Services Group Inc   17.53 %

Date modified: 2026-09-26T07:15:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.